Evidence map›Paper›PMID 33082675›Full record

ArticleIndian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

The Utility of

Manish Ora, Aftab Hasan Nazar, Prasanta Kumar Pradhan, Prabhakar Mishra, Sukanta Barai, Amitabh Arya, Manish Dixit, Ashutosh Parashar, Sanjay Gambhir

Open access · greenAbstract read
In one paragraph

Article in Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. 2-[Diagnostics (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Manish OraDepartment of Nuclear Medicine, SGPGIMS, Lucknow, Uttar Pradesh, India.
Aftab Hasan NazarDepartment of Nuclear Medicine, SGPGIMS, Lucknow, Uttar Pradesh, India.
Prasanta Kumar PradhanDepartment of Nuclear Medicine, SGPGIMS, Lucknow, Uttar Pradesh, India.
Prabhakar MishraDepartment of Biostatistics and Health Informatics, SGPGIMS, Lucknow, Uttar Pradesh, India.
Sukanta BaraiDepartment of Nuclear Medicine, SGPGIMS, Lucknow, Uttar Pradesh, India.
Amitabh AryaDepartment of Nuclear Medicine, SGPGIMS, Lucknow, Uttar Pradesh, India.
Manish DixitDepartment of Nuclear Medicine, SGPGIMS, Lucknow, Uttar Pradesh, India.
Ashutosh ParasharDepartment of Nuclear Medicine, SGPGIMS, Lucknow, Uttar Pradesh, India.
Sanjay GambhirDepartment of Nuclear Medicine, SGPGIMS, Lucknow, Uttar Pradesh, India.
Sanjay Gandhi Post Graduate Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of the studyMATERIALS AND

methodsIn a retrospective study, we analyzed 137 PET/CT done on DTC patients presented with raised Tg/Atg and negative WBS. Retrospective evaluation of other available clinical information was done.

resultsOne hundred and thirty-seven patients aged 8-72 years (41 ± 17.7 years) were included in the study. Eighty-nine (64.9%) patients had positive findings on

conclusionsPET/CT is an excellent imaging modality for evaluating DTC patients presented with biochemical recurrence. It not only finds the disease in more than 80% of the patients but also detects distant metastatic disease, which precludes regional therapies. Lesions were noted mostly in the neck and thoracic region with very few distant skeletal metastases (4/137 patients). In most of the patients, routine vertex to mid-thigh imaging could be avoided.

Indexed as

18F-fluorodeoxyglucose positron emission tomography/computed tomographyrecurrent thyroid cancerserum antithyroglobulin antibodyserum thyroglobulinthyroglobulin elevation/negative iodine scintigraphy syndromethyroid cancer

Identifiers

PMID33082675
PMCPMC7537939
OpenAlexW3038269676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.